Clinical Trial Update: Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation Therapy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating lung perfusion PET/CT using Ga68-MAA to preserve lung function during stereotactic body radiotherapy for lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University Hospital, Brest | Conditions: SBRT, Non-small Cell Lung Cancer | Phase 2, Phase 3 | Status: UNKNOWN